Abstract
The use of inhibitors of angiotensin-converting enzyme (ACE) is strongly indicated by a diagnosis of congestive heart failure (CHF) with deteriorated systolic function (SF), but their effects on patients with CHF but no systolic deterioration have not been clarified. We focused this study on the evaluation of the influence of ACE inhibitors on survival among CHF patients with preserved SF, but also determined the effect of these drugs on the prognosis of our patients with deteriorated SF. We studied 416 patients, aged 72.7 +/- 10.2 years, who between January 1, 1991, and December 31, 2001, were admitted to the cardiology service of a tertiary hospital for CHF and who fulfilled the requirements that left ventricular SF that had been evaluated echocardiographically during hospitalization was preserved and that data were available on medication at the time of their release from hospital. Two hundred four patients (49.0%) were men, 250 (60.8%) were hypertensive, and, in 171 (41.1%) cases, ischemic cardiopathy was the primary cause of the CHF. ACE inhibitors were prescribed to 210 patients (50.5%) on hospital release. Kaplan-Meier survival curve analysis showed that, among patients with preserved SF, a longer survival was associated...Continue Reading
References
Apr 1, 1993·Hypertension·A M HeagertyM J Mulvany
Jan 1, 1996·European Heart Journal·R NarangJ G Cleland
Mar 15, 1997·Lancet·B PittP I Chang
Aug 26, 1998·European Heart Journal
May 23, 2000·Lancet·M D FlatherE Braunwald
Aug 10, 2000·European Journal of Heart Failure·J G ClelandJ Taylor
Dec 2, 2000·The American Journal of Medicine·E F PhilbinP L Jenkins
Mar 27, 2002·Circulation·Michael R Zile, Dirk L Brutsaert
Jun 6, 2003·Lancet·Philip JongShrikant I Bangdiwala
Mar 18, 2005·Heart·A Varela-RomanJ R Gonzalez-Juanatey
Citations
Feb 5, 2008·Heart Failure Reviews·Yi-Da Tang, Stuart D Katz
Sep 4, 2008·Current Heart Failure Reports·Haroon A FarazJalal K Ghali
Sep 16, 2009·The Pharmacogenomics Journal·C-K WuF-T Chiang
Aug 9, 2011·European Heart Journal·UNKNOWN Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)
Jul 8, 2011·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Judy Ying ChenRichard S Chung
Mar 7, 2014·PloS One·Feng LiuJianping Bin
Jun 9, 2012·Heart Failure Reviews·Vikram AgarwalFranz H Messerli
Mar 19, 2013·The American Journal of the Medical Sciences·Nadish GargMartin A Alpert
Sep 12, 2015·European Journal of Heart Failure·Joanne SimpsonUNKNOWN Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC)
Apr 13, 2011·International Journal of Cardiology·Mingqiang FuJunbo Ge
Apr 7, 2009·Trends in Cardiovascular Medicine·Michael KindermannMichael Böhm
Aug 6, 2009·European Journal of Heart Failure·Jithendra B SomaratneGillian A Whalley
Nov 27, 2008·American Heart Journal·Lilian Grigorian-ShamagianJose Ramon Gonzalez-Juanatey
Apr 18, 2015·Journal of cardiology·Kazuhiro Yamamoto
Dec 10, 2008·International Journal of Cardiology·Francisco M Gomez-SotoFrancisco Gomez
Mar 3, 2010·International Journal of Cardiology·Redi PeciniLars Køber
Apr 16, 2011·Journal of the American College of Cardiology·David J HollandThomas H Marwick
Mar 1, 2008·The American Journal of Cardiology·Christophe TribouilloyMichel Slama
Jul 19, 2014·Heart Failure Reviews·Chirag BavishiFranz H Messerli
Jan 5, 2011·Journal of Cardiovascular Pharmacology and Therapeutics·Christophe MeuneSimon Weber
Sep 5, 2017·ESC Heart Failure·Muhammad Shahzeb KhanJaved Butler
Jan 30, 2019·International Journal of Clinical Practice·Jose J EgidoFrancisco Gomez
Mar 20, 2019·Internal Medicine Journal·Lourdes VicentManuel Martínez-Sellés
Jul 14, 2017·Heart Failure Reviews·Hidekatsu FukutaNobuyuki Ohte
Aug 8, 2018·European Heart Journal·Christopher J RushJohn J V McMurray
Apr 3, 2020·Internal Medicine Journal·Lourdes VicentManuel Martinez-Sellés
Nov 10, 2021·Expert Review of Cardiovascular Therapy·Jerald PelayoJanani Rangaswami